2006
DOI: 10.1016/j.neuron.2006.04.016
|View full text |Cite
|
Sign up to set email alerts
|

A Shared Vesicular Carrier Allows Synaptic Corelease of GABA and Glycine

Abstract: The type of vesicular transporter expressed by a neuron is thought to determine its neurotransmitter phenotype. We show that inactivation of the vesicular inhibitory amino acid transporter (Viaat, VGAT) leads to embryonic lethality, an abdominal defect known as omphalocele, and a cleft palate. Loss of Viaat causes a drastic reduction of neurotransmitter release in both GABAergic and glycinergic neurons, indicating that glycinergic neurons do not express a separate vesicular glycine transporter. This loss of GA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

20
331
2
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 334 publications
(354 citation statements)
references
References 57 publications
(85 reference statements)
20
331
2
1
Order By: Relevance
“…S1 J, S7D, available at www.jneurosci.org as supplemental material). Together with previous work (Ludwig et al, 2003;Titz et al, 2003;Wojcik et al, 2006), our results do not support a role of depolarizing GABA in inducing KCC2 expression, an effect previously reported in cultured neurons (Ganguly et al, 2001). , and Olig1 (found in independent screen) at different ages during development (normalized to WT Ϯ SEM; n Ͼ 3 animals per genotype and age).…”
Section: Delayed Maturation Of Glutamatergic and Gabaergic Transmissicontrasting
confidence: 52%
“…S1 J, S7D, available at www.jneurosci.org as supplemental material). Together with previous work (Ludwig et al, 2003;Titz et al, 2003;Wojcik et al, 2006), our results do not support a role of depolarizing GABA in inducing KCC2 expression, an effect previously reported in cultured neurons (Ganguly et al, 2001). , and Olig1 (found in independent screen) at different ages during development (normalized to WT Ϯ SEM; n Ͼ 3 animals per genotype and age).…”
Section: Delayed Maturation Of Glutamatergic and Gabaergic Transmissicontrasting
confidence: 52%
“…106,155,156 This filling process, however, requires activity of a vacuolar H þ -ATPase that provides the electrical (DC) and chemical (DpH) components of the driving force for the vesicular inhibitory amino-acid transporter. 147,157 After release to the synaptic cleft, re-uptake of GABA occurs via Na þ -/Cl À -dependent GABA transporter 1 in the presynaptic terminal or via GAT-3 in processes of astrocytes that enwrap the synapse. Again, these processes are secondarily active, thus utilizing potential energy that has been previously provided by the Na þ /K þ -ATPase and other transport systems.…”
Section: Energy Utilization Of Fast-spiking Behavior and Synaptic Inhmentioning
confidence: 99%
“…Changes in the function or expression of these transporters can modify the quantal size of synaptic potentials. 319 Plasma membrane transporters regulate the activity of neurotransmitters including GABA and biogenic amines by sequestering them into cells after they are released from nerve terminals. They couple transmembrane movement of Na ϩ and Cl Ϫ (and in some systems, K ϩ ) to the reuptake of the neurotransmitter.…”
Section: Neurotransmitter Transportersmentioning
confidence: 99%